The Role of Radial Peripapillary Vessel Density in Irvine-gass Syndrome
OCTA and PMCE
Radial Peripapillary Vessel Density as a New Biomarker in Irvine-Gass Syndrome
1 other identifier
observational
30
1 country
1
Brief Summary
Pseudophakic cystoid macular edema (PCME), also known as Irvine-Gass syndrome (IGS), is an accumulation of fluid in the macula that occurs after cataract surgery, with an early or late presentation (cut-off 3 months) . It is the most common cause of decreased vision after uneventful phacoemulsification, with a rare incidence of 0.1-2.35% for clinically significant PCME . Macular edema in IGS can be diagnosed and classified by optical coherence tomography (OCT), which enables its morphologic assessment. Fluorescein angiography (FA) is the gold standard to perform differential diagnosis for macular edema. To date, OCT angiography (OCTA) has been proposed to study various retinal vascular diseases. In contrast to FA, OCTA is able to visualize Radial peripapillary vessel density (RCP). The aim of this study was to investigate abnormalities in the vascular network of the optic nerve head in patients with IGS compared to healthy eyes, using OCT-A
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jul 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 29, 2024
CompletedFirst Submitted
Initial submission to the registry
May 21, 2024
CompletedFirst Posted
Study publicly available on registry
May 30, 2024
CompletedMay 30, 2024
May 1, 2024
6 months
May 21, 2024
May 28, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
the role of OCTA in diagnosis of IGS
To evaluate the vascolarization of RPC in IGS
10 months
Study Arms (2)
30 patiens with IGS mean age 70 ±6
30 healthy controls mean age 70 ±5
Interventions
OCTA is a non invasive diagnostic technique to visualize RPC
Eligibility Criteria
All patients with a diagnosis of PCME following phacoemulsification, addressed to our Unit, were enrolled in the study. The diagnostic criteria for PCME were: 1) vision loss in the operated eye within 3 months after surgery in patients with acute PCME and after 3 months for patients with chronic PCME; 2) changes on B-scan structural OCT with intraretinal cystoid spaces and central macular thickness (CMT) of at least 300 micron; 3) leakage and pooling of dye in macular cystoid spaces and late hyperfluorescence of the optic nerve head on FA. Clinical suspicion of PCME was confirmed using FA and structural OCT.
You may qualify if:
- Clinical diagnosis of PCME Cataract surgery
You may not qualify if:
- diabetes vein occlusion uveitis vasculitis age-related macular degeneration hereditary macular dystrophy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Federico II of Naples
Naples, 80121, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 21, 2024
First Posted
May 30, 2024
Study Start
July 1, 2023
Primary Completion
December 30, 2023
Study Completion
April 29, 2024
Last Updated
May 30, 2024
Record last verified: 2024-05